Bid outcomes
How their decided bids ended, by number and by valueWhere they win
12 authorities · 10 statesTop buyer organisations
Operating states
Top competitors
In tenders they both bid · bar shows how the awards splitRecent tenders awarded to Novo Nordisk
- T-879/MPPHSCL/Pharma/RC/2026 Date-24-03-2026Madhya Pradesh Public Health Services Corporation Ltd. · Madhya Pradesh · 25 Aug 2026₹5.2 Cr
- E-211/MMGPA/ Extended half life factor VIII 500 IU /Vial (DHS)Maharashtra Medical Goods Procurement Authority Mumbai · Maharashtra · 16 Jul 2026₹4.5 Cr
- Anti Hemophilic DrugsTamilnadu Medical Services Corporation · Tamil Nadu · 13 Jul 2026₹38,027
- e-Tender for procurement of MedicineSecretary Health and Family Welfare Department · Tripura · 1 Jul 2026₹95.6 L
- Inj. Glycopegylated Extended half life recombinant Factor VIII-500IUMunicipal Corporation of Greater Mumbai · Maharashtra · 30 Apr 2026₹9.2 L
About Novo Nordisk India Private Limited
Novo Nordisk India Private Limited appears as a bidder on 24 government tenders on record, from 16 buyer authorities in 11 states. Of its 21 decided bids, it was awarded 16 — a 76.2% win rate — worth ₹28.7 Cr in total. Its most recent award on record is from 25 Aug 2026.
Its largest buyer by awarded value is GOA MEDICAL COLLEGE AND HOSPITAL, at 31.5% of what it has won, out of 12 authorities that have awarded it work. Most of its awards come from Goa, Madhya Pradesh and Maharashtra. On priced bids, its median quote is the lowest (L1).
It most often bids against Reliance Life Sciences Pvt. Ltd, Grifols India Healthcare Private Limited and Glenmark Pharmaceuticals Limited. Reliance Life Sciences Pvt. Ltd bid on 11 of the same tenders and won 9 of them; Novo Nordisk India Private Limited won 6.